Clinical Pharmacology: Advances and Applications
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
An Author's Guide
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Editor-in-Chief: Professor Arthur E. Frankel
Dr. Arthur Frankel is a Professor at the Department of Internal Medicine, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center.
Dr. Frankel earned his MD from Harvard Medical School and conducted his Medicine Internship at Yale University. Soon after completing his degree, Dr. Frankel began as a Research Scientist with the National Institute of Health and later completed his Medicine Residency and Oncology Fellowship at Stanford University. He is Board Certified in Internal Medicine, Medical Oncology and Hematology. Dr. Frankel is a member of the American Society of Clinical Oncology, American Society of Hematology and American Association of Cancer Research.
Dr. Frankel's main focus is combining the clinical practice of hematology/oncology with an investigative cancer drug development program to better move targeted cancer therapeutics into the clinical setting. He has participated in the development of targeted peptide toxins also called immunotoxins for melanoma, breast cancer, ovarian cancer, leukemia, lymphoma, chronic pain, prostate cancer, and thyroid cancer. He has performed phase I clinical trials for many of these agents. He has over 190 peer-reviewed articles, has edited three books, organized for international symposia and received grants from the American Cancer Society, the Leukemia and Lymphoma Society, NIH and the Van Andel Foundation.